awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36598514-6D56A6A8-2C64-430A-B4B2-68A72CEF29B4
Q36598514-6D56A6A8-2C64-430A-B4B2-68A72CEF29B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36598514-6D56A6A8-2C64-430A-B4B2-68A72CEF29B4
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma.
P2860
Q36598514-6D56A6A8-2C64-430A-B4B2-68A72CEF29B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36598514-6D56A6A8-2C64-430A-B4B2-68A72CEF29B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87a621ee2f4359f45a6f0568d49cc8f161269afa
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.